HPTN 083 Trial Contributes to FDA’s Approval of new HIV Prevention Medication
UCLA Press release: Meth use, intimate partner violence weaken immune function in HIV-positive men
ASCEND: Therapeutic Interventions for Methamphetamine Dependence Webinar
Dr. Steven Shoptaw Named Presenter for the 2021 Eric D. Hadar Distinguished Lecture Series
Opioid Addiction Recovery Support (OARS) Software Developed by Q2i in Partnership with UCLA Advances to Efficacy Evaluation Stage in National Institute of Health (NIH) Clinical Trial
We’re Going Mobile


CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.